SYNSIRNA

Johnson & Johnson

Application Filed: 2021-06-10

Trademark Application Details

Mark For: SYNSIRNA™ trademark registration is intended to cover the categories of human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives. [all]

Status

2022-09-30 UTC

DEAD APPLICATION Refused Dismissed or Invalidated

This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.

Research	OneLook Acronym Finder
Serial Number	90765834
Mark Literal Elements	SYNSIRNA
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	TRADEMARK
Register	PRINCIPAL
Current Location	TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED 2022-09-07
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	005: Adhesives 006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Cheryl L. Foytlin
Attorney Docket Number	T36719US2

Timeline

2021-06-10	Application Filed
2021-06-14	Location: NEW APPLICATION PROCESSING
2021-06-14	Status: Live/Pending
2021-06-14	Transaction Date
2022-09-07	Location: TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED
2022-09-07	Status: Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this fi

Trademark Parties (Applicants & Owners)

Party:	JOHNSON & JOHNSON
Address	One Johnson & Johnson Plaza New Brunswick, NEW JERSEY UNITED STATES 08933
Legal Entity Type	Corporation
Legal Entity State	NEW JERSEY

Party:	JOHNSON & JOHNSON
Address	One Johnson & Johnson Plaza New Brunswick NJ 08933
Legal Entity Type
Legal Entity State	NJ

*multiple parties listed, check assignment documents for ownership information

Documents

Application		2021-06-10
Drawing		2021-06-10
Notation to File		2022-02-11
Offc Action Outgoing		2022-02-11
XSearch Search Summary		2022-02-11
Abandonment-Notice		2022-09-07
Notice of Abandonment		2022-09-07

Attorney of Record

CHERYL L. FOYTLIN
JOHNSON & JOHNSON
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NJ 08933

Good, Services, and Codes

(ABANDONED)
IC 005. US 005 006 018 044 046 051 052. G & S: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

International Codes:	5
U.S. Codes:	005,006,018,044,046,051,052

Type Code	Type
GS0051	Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Type Code

Type

GS0051

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Trademark Filing History

Description	Date	Proceeding Number
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND	2022-09-07
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND	2022-09-07
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE	2022-09-07
ASSIGNED TO EXAMINER	2022-05-06	92999
NOTIFICATION OF NON-FINAL ACTION E-MAILED	2022-02-11	6325
NON-FINAL ACTION WRITTEN	2022-02-11	92455
NON-FINAL ACTION E-MAILED	2022-02-11	6325
ASSIGNED TO EXAMINER	2022-02-07	92455
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2021-08-30
NEW APPLICATION ENTERED IN TRAM	2021-06-14

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
SYNSIRNA 90765834 not registered Live/Pending	JOHNSON & JOHNSON 2021-06-10
SYNSIRNA 87690936 not registered Live/Pending	JOHNSON & JOHNSON 2017-11-20
SYNSIRNA 86307986 not registered Dead/Abandoned	Glaxo Group Limited 2014-06-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.